lenvatinib,sunitinib,everolimus,pembrolizumab
merck,pfizer,eisai
['sunitinib', 'gu ', 'clear study', 'pembro', 'rcc,(-irccs),(-srcc),(-urcc)', 'lenva']
dr. tom hutson delivering perfect presentation of 4-yr os results (hr 0.79 (0.63-0.99)) from the clear study (lenvatinib/pembro v sunitinib in adv rcc) in gu oral session #asco23 
Chief Scientific Officer, Sarah Cannon Research Institute; Thoracic Medical Oncology, Tennessee Oncology